基本信息
views: 59
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
NIH supported trial conducted in 22 clinical centers in the United States. OHTS was the first trial to demonstrate definitively that treatment of elevated intraocular pressure (IOP) delays or prevents the onset of glaucomatous damage. OHTS identified risk factors for developing primary open-angle glaucoma (POAG) including older age, higher IOP and larger cup/disc ratio. OHTS was the first study to identify central corneal thickness (CCT) as an independent risk factor for the development of POAG. OHTS determined that delaying treatment of ocular hypertension for several years’ results in only a small increase in the incidence of open-angle glaucoma in low-risk patients. In contrast, delaying treatment in high-risk patients substantially increases the incidence of open-angle glaucoma. We are now working to improve the prediction model by considering other potential risk factors such as axial length, perfusion pressure and optic disc size. We are also investigating genetic factors that control quantitative traits of the eye that may be linked to glaucoma including corneal thickness and intraocular pressure. The papers listed below summarize the published outcomes of OHTS.
Research Interests
Papers共 271 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
STATno. 1 (2024)
Investigative ophthalmology & visual scienceno. 2 (2024): 35-35
JAMA ophthalmologyno. 4 (2024): 356-363
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCEno. 8 (2023)
Cited0Views0Bibtex
0
0
medRxiv : the preprint server for health sciences (2023)
Ophthalmology. Glaucomano. 6 (2023): 592-598
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCEno. 8 (2023)
Cited0Views0Bibtex
0
0
Cited0Views0Bibtex
0
0
Load More
Author Statistics
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn